Copyright
©2011 Baishideng Publishing Group Co.
World J Diabetes. Jan 15, 2011; 2(1): 8-15
Published online Jan 15, 2011. doi: 10.4239/wjd.v2.i1.8
Published online Jan 15, 2011. doi: 10.4239/wjd.v2.i1.8
Table 1 Baseline characteristics of subjects without metabolic syndrome and five-year occurrence rates of metabolic syndrome
Baseline data | Overall | Female | Male |
N = 1384 | n = 388 | n = 996 | |
Measurements; mean (standard deviation) | |||
Age (year) | 32.3 (6.5) | 32.8 (7.9) | 32.1 (5.9) |
Body weight (kg)a | 63.7 (10.9) | 54.2 (8.0) | 67.4 (9.6) |
Body mass index (kg/m2)a | 23.0 (3.0) | 22.0 (3.1) | 23.4 (2.9) |
Waist (cm)a | 75.6 (8.6) | 68.5 (6.9) | 78.3 (7.6) |
Systolic blood pressure (mmHg)a | 117.0 (14.3) | 111.5 (13.4) | 119.2 (14.1) |
Diastolic blood pressure (mmHg)a | 71.7 (9.2) | 68.6 (8.9) | 72.9 (9.0) |
Fasting blood glucose (mg/dL) | 94.3 (13.2) | 93.8 (8.2) | 94.5 (14.8) |
Triglycerides (mg/dL)a | 102.5 (78.0) | 75.1 (39.3) | 113.1 (86.3) |
HDL cholesterol (mg/dL)a | 50.5 (11.8) | 55.6 (12.5) | 48.6 (11.0) |
Prevalent rates (%) | |||
Central obesity | 3.90% | 4.60% | 3.60% |
Hyperglycemia | 20.50% | 20.10% | 20.70% |
High blood pressurea | 17.70% | 8.50% | 21.30% |
Hypertriglyceridemiaa | 13.70% | 4.10% | 17.50% |
Low-HDL cholesterolemiaa | 24.40% | 35.30% | 20.20% |
Lifestyle | |||
Physical exercise; ≥ 3 times a weeka | 32.10% | 25.50% | 34.60% |
Habitual drinkera | 7.20% | 0.30% | 9.90% |
Having snacks before sleeping (≥ third a week)a | 39.50% | 31.70% | 42.50% |
Having snacks between meals (≥ third a week)a | 46.50% | 61.10% | 40.90% |
Ever been a smoker (yes vs no)a | 32.20% | 5.20% | 42.70% |
MetS development within 5 yearsa | 12.60% | 8.80% | 14.20% |
Table 2 Summary of baseline characteristics of variables for the total population and five-year occurrence rates of metabolic syndrome according to the severity of weight gain (N = 1384)
Baseline data | WG within 5 years | |||
Control | Mild | Moderate | Severe | |
%WG ≤1% | 1% < %WG ≤5% | 5% < %WG ≤10% | %WG > 10% | |
n = 341 | n =337 | n =387 | n =391 | |
Measurements; mean (standard deviation) | ||||
Age (year)b | 33.5 (6.8) | 33.3 (6.4) | 32.4 (6.4) | 29.7 (5.7) |
Body weight (kg) | 64.4 (10.5) | 63.9 (11.8) | 63.6 (11.0) | 62.9 (10.3) |
Body mass index (kg/m2) | 23.3 (2.8) | 23.1 (3.0) | 23.0 (3.2) | 22.6 (2.9) |
Waist (cm) | 76.0 (8.2) | 75.8 (8.9) | 75.8 (9.1) | 74.5 (8.0) |
Systolic blood pressure (mmHg)a | 118.9 (14.5) | 116.4 (14.4) | 117.0 (15.0) | 115.7 (13.3) |
Diastolic blood pressure (mmHg)b | 73.3 (9.4) | 71.7 (9.3) | 71.5 (9.8) | 70.2 (7.8) |
Fasting blood glucose (mg/dL)a | 95.8 (15.1) | 94.5 (7.9) | 93.9 (7.4) | 92.8 (19.5) |
Triglycerides (mg/dL)b | 115.4 (118.8) | 105.5 (65.0) | 98.8 (55.9) | 89.9 (52.2) |
HDL cholesterol (mg/dL) | 49.2 (11.0) | 50.6 (12.7) | 50.8 (12.6) | 51.6 (10.7) |
Prevalent rates (%) | ||||
Lifestyle factors | ||||
Physical exercise; > 3 times a week | 34.90% | 30.90% | 31.30% | 31.30% |
Habitual drinker | 6.20% | 7.10% | 8.50% | 3.90% |
Having snacks before sleeping (≥ third a week)b | 34.00% | 35.90% | 44.20% | 43.30% |
Having snacks between meals (≥ third a week) | 46.60% | 43.60% | 47.00% | 48.90% |
Ever been a smoker (yes vs no) | 31.10% | 29.70% | 33.10% | 34.80% |
MetS development within 5 years | 9.10%b | 9.50%b | 15.80%b | 16.00%b |
Table 3 Summary of baseline characteristics of variables for female and male adults according to the severity of weight gain
Female N = 388 | ||||
Baseline data | WG within 5 years | |||
Control | Mild | Moderate | Severe | |
%WG ≤1% | 1% < %WG ≤5% | 5% < %WG ≤10% | %WG >10% | |
n = 105 | n = 100 | n = 99 | n = 84 | |
Measurements; mean (standard deviation) | ||||
Age (year) | 33.6 (8.7) | 33.0 (7.4) | 33.1 (8.1) | 31.1 (7.0) |
Body weight (kg) | 55.3 (7.3) | 53.0 (7.5) | 53.5 (8.3) | 55.3 (8.8) |
Body mass index (kg/m2)b | 23.9 (2.7) | 23.8 (2.8) | 23.3 (3.0) | 22.6 (2.8) |
Waist (cm) | 68.8 (5.9) | 67.8 (6.4) | 68.1 (7.9) | 69.5 (7.2) |
Systolic blood pressure (mmHg) | 112.2 (13.8) | 109.7 (12.1) | 113.2 (14.6) | 110.6 (12.9) |
Diastolic blood pressure (mmHg) | 68.9 (9.0) | 67.7 (8.8) | 69.8 (9.6) | 67.7 (8.1) |
Fasting blood glucose (mg/dL) | 94.0 (9.1) | 94.7 (8.6) | 94.2 (7.0) | 91.9 (7.4) |
Triglycerides (mg/dL) | 79.4 (38.3) | 73.4 (33.6) | 74.0 (33.1) | 73.2 (51.9) |
HDL cholesterol (mg/dL) | 53.2 (11.6) | 57.1 (12.9) | 56.4 (14.4) | 55.6 (10.2) |
Prevalent rates (%) | ||||
Lifestyle factors | ||||
Physical exercise; ≥ 3 times a week | 25.70% | 26.00% | 23.20% | 27.40% |
Habitual drinker | 1.00% | 0.00% | 0.00% | 0.00% |
Having snacks before sleeping (≥ third a week) | 28.60% | 26.00% | 44.40% | 27.40% |
Having snacks between meals (≥ third a week) | 59.00% | 55.00% | 74.70% | 54.80% |
Ever been a smoker (yes vs no) | 6.70% | 3.00% | 4.00% | 7.10% |
Male N = 996 | ||||
Baseline data | WG within 5 years | |||
Control | Mild | Moderate | Severe | |
%WG ≤1% | 1% < %WG ≤5% | 5% < %WG ≤10% | %WG > 10% | |
n = 236 | n = 237 | n = 288 | n = 235 | |
Measurements; mean (standard deviation) | ||||
Age (year)b | 33.4 (5.7) | 33.5 (6.0) | 32.2 (5.7) | 29.2 (5.0) |
Body weight (kg)b | 68.5 (9.0) | 68.6 (10.1) | 67.1 (9.6) | 65.6 (9.5) |
Body mass index (kg/m2) | 22.2 (2.8) | 21.6 (2.8) | 21.8 (3.5) | 22.4 (3.1) |
Waist (cm)b | 79.3 (7.0) | 79.2 (7.5) | 78.4 (7.9) | 76.3 (7.5) |
Systolic blood pressure (mmHg)b | 121.8 (13.8) | 119.2 (14.3) | 118.2 (14.9) | 117.6 (13.0) |
Diastolic blood pressure (mmHg)b | 75.2 (8.9) | 73.4 (8.9) | 72.0 (9.8) | 71.1 (7.6) |
Fasting blood glucose (mg/dL) | 96.6 (17.1) | 94.4 (7.6) | 93.8 (7.5) | 93.2 (22.3) |
Triglycerides (mg/dL)b | 131.5 (137.6) | 119.1 (70.2) | 107.3 (59.5) | 95.9 (51.1) |
HDL cholesterol (mg/dL)a | 47.4 (10.3) | 47.9 (11.5) | 48.8 (11.3) | 50.1 (10.5) |
Prevalent rates (%) | ||||
Lifestyle factors | ||||
Physical exercise; ≥ 3 times a week | 39.00% | 32.90% | 34.00% | 32.80% |
Habitual drinker | 8.50% | 10.10% | 11.50% | 9.40% |
Having snacks before sleeping (≥ third a week)a | 36.40% | 40.10% | 44.10% | 48.90% |
Having snacks between meals (≥ third a week) | 41.10% | 38.80% | 37.50% | 46.80% |
Ever been a smoker (yes vs no) | 41.90% | 40.90% | 43.10% | 44.70% |
Table 4 Summary of five-year changes in metabolic syndrome-components for female and male adults and the occurrence rates of metabolic syndrome according to the severity of weight gain
Female N = 388 | ||||
Follow-up changes (%) | WG within 5 years | |||
Control | Mild | Moderate | Severe | |
%WG ≤1% | 1% < %WG ≤5% | 5% < %WG ≤10% | %WG > 10% | |
n = 105 | n = 100 | n = 99 | n = 84 | |
△Central obesityb | 8.50% | 16.00% | 22.60% | 32.80% |
△High blood pressure | 22.90% | 28.70% | 28.50% | 37.00% |
△Hyperglycemia | -3.40% | -4.20% | -3.10% | 1.30% |
△Hypertriglyceridemiab | -0.40% | 8.00% | 15.60% | 24.30% |
△Low-HDL cholesterolb | -14.40% | -17.70% | -5.90% | -6.00% |
MetS Development within 5 yearsb | 5.70% | 3.00% | 14.10% | 13.10% |
Male N = 996 | ||||
Follow-up changes (%) | WG within 5 years | |||
Control | Mild | Moderate | Severe | |
%WG ≤1% | 1% < %WG ≤5% | 5% < %WG ≤10% | %WG > 10% | |
n = 236 | n = 237 | n = 288 | n = 235 | |
△Central obesityb | 10.00% | 3.00% | 21.20% | 40.50% |
△High blood pressurea | 21.00% | 20.00% | 21.20% | 19.00% |
△Hyperglycemia | -8.00% | -11.00% | -5.10% | -2.40% |
△Hypertriglyceridemiab | 2.00% | 2.00% | 8.10% | 11.90% |
△Low-HDL cholesterolb | -34.00% | -24.00% | -24.20% | -7.10% |
MetS development within 5 years | 10.60% | 12.20% | 16.30% | 17.00% |
Table 5 The adjusted risks for development of metabolic syndrome
WG severities | Odd ratio | 95% CI |
Total population | ||
Mild WG (1% < %WG < 5%) | 1.2 | 0.70 - 2.2 |
Moderate WG (5% < %WG < 10%)b | 3.0 | 1.80 - 5.1 |
Severe WG (%WG > 10%)b | 5.4 | 3.00 - 9.7 |
Female | ||
Mild WG (1% < %WG < 5%) | 0.9 | 0.20 - 4.5 |
Moderate WG (5% < %WG < 10%)a | 3.6 | 1.03 - 12.4 |
Severe WG (%WG > 10%)b | 5.5 | 1.40 - 21.4 |
Male | ||
Mild WG (1% < %WG < 5%) | 1.4 | 0.70 - 2.7 |
Moderate WG (5% < %WG < 10%)b | 3/0 | 1.60 - 5.5 |
Severe WG (%WG > 10%)b | 5.2 | 2.60 - 10.2 |
- Citation: Lin YC, Chen JD, Chen PC. Excessive 5-year weight gain predicts metabolic syndrome development in healthy middle-aged adults. World J Diabetes 2011; 2(1): 8-15
- URL: https://www.wjgnet.com/1948-9358/full/v2/i1/8.htm
- DOI: https://dx.doi.org/10.4239/wjd.v2.i1.8